Bulletin
Investor Alert

New York Markets Close in:

Protagonist Therapeutics Inc.

NAS: PTGX

GO
/marketstate/country/us

Market open

 --Real time quotes

May 20, 2022, 2:22 p.m.

/zigman2/quotes/205674595/composite

$

7.53

Change

-0.24 -3.09%

Volume

Volume 618,969

Real time quotes

/zigman2/quotes/205674595/composite

Previous close

$ 7.77

$ 7.53

Change

-0.24 -3.09%

Day low

Day high

$7.48

$7.94

Open

52 week low

52 week high

$7.48

$50.54

Open

Samuel R. Saks

Dr. Samuel R. Saks, MD, is a Chief Medical Officer at Protagonist Therapeutics, Inc. He is on the Board of Directors at NuMedii, Inc., Bullet Biotechnology, Inc., Velocity Pharmaceutical Development LLC and Quanta Therapeutics, Inc. Dr. Saks was previously employed as an Independent Director by PDL BioPharma, Inc., an Independent Director by Tonix Pharmaceuticals Holding Corp., a Chief Medical Officer by Threshold Pharmaceuticals, Inc., a Director & Chief Development Officer by Auspex Pharmaceuticals, Inc., a Chief Executive Officer by Jazz Pharmaceuticals, Inc., a Group Chairman by ALZA Corp., a Professor by University of California, a Group Vice President by ALZA Pharmaceuticals, a Principal by Genentech, Inc., an Advisor by CMEA Capital, an Advisor by ProQuest Investments, a Principal by Schering-Plough Corp., and a Vice President-Clinical Research by XOMA Corp. He also served on the board at Depomed, Inc., Cougar Biotechnology, Inc. /Old/, Trubion Pharmaceuticals, Inc., Corixa Corp., Coulter Pharmaceuticals, Inc., Hinge Bio, Inc., Ilypsa, Inc., Qwell Pharmaceuticals, Inc. and Sirna Therapeutics, Inc. He received his undergraduate degree from the University of Illinois and a doctorate degree from the University of Illinois.

Transactions

Date Shares Transaction Value
02/26/2021 12,000   Award at $0 per share. 0
02/28/2019 2,500   Award at $0 per share. 0

Officers and Executives

Dr. Dinesh V. Patel
President, Chief Executive Officer & Director
Mr. Asif Ali
Chief Financial Officer & Executive Vice President
Dr. Paula O’Connor
Senior Vice President-Clinical Development
Dr. Mohammad Masjedizadeh
Chief Technical officer & Executive VP
Dr. Mark L. Smythe
Vice President-Technology
Dr. David Y. Liu
Chief Research & Development Strategy Officer
Dr. Samuel R. Saks
Chief Medical Officer
Ms. Tracy M. Woody
Executive Vice President-Commercial Strategy
Dr. Scott Plevy
Executive Vice President & Head-Gastroenterology
Mr. Jami Taylor
Vice President-Corporate Affairs
Dr. Ashok Bhandari
Senior Director-Chemistry
Mr. Carter J. King
Vice President-Business Development
Dr. Suneel Gupta
Chief Development Officer
Ms. Carena Spivey
Executive Director-Human Resources
Mr. Matthew M. Gosling
Executive Vice President & General Counsel
Dr. Harold E. Selick
Chairman
Ms. Sarah A. O'Dowd
Independent Director
Mr. William D. Waddill
Independent Director
Dr. Lewis T. Williams
Independent Director
Dr. Sarah B. Noonberg
Independent Director
Mr. Bryan Giraudo
Independent Director
Link to MarketWatch's Slice.